Taro Pharmaceutical Indus: Q1 Earnings Insights

Taro Pharmaceutical Indus TARO reported its Q1 earnings results on Wednesday, July 27, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.

Taro Pharmaceutical Indus missed estimated earnings by 56.47%, reporting an EPS of $0.37 versus an estimate of $0.85.

Revenue was up $9.55 million from the same period last year.

Last quarter the company missed on EPS by $0.15 which was followed by a 3.89% increase in the share price the next day.

Here's a look at Taro Pharmaceutical Indus's past performance:

Quarter	Q4 2022	Q3 2022	Q2 2022	Q1 2022
EPS Estimate	0.88	0.91	1.02	0.84
EPS Actual	0.73	0.70	0.66	1.09
Revenue Estimate	147.01M	142.22M	153.23M	137.23M
Revenue Actual	143.26M	139.00M	131.99M	147.11M

To track all earnings releases for Taro Pharmaceutical Indus visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.